Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms

被引:564
作者
Andorfer, C
Kress, Y
Espinoza, M
de Silva, R
Tucker, KL
Barde, YA
Duff, K
Davies, P
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA
[3] UCL, Reta Lila Weston Inst Neurol Studies, London, England
[4] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
[5] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY USA
关键词
aggregation; Alzheimer's disease; non-mutant tau; phosphorylation; transgenic;
D O I
10.1046/j.1471-4159.2003.01879.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibrillary tangles are composed of insoluble aggregates of the microtubule-associated protein tau. In Alzheimer's disease the accumulation of neurofibrillary tangles occurs in the absence of tau mutations. Here we present mice that develop pathology from non-mutant human tau, in the absence of other exogenous factors, including beta-amyloid. The pathology in these mice is Alzheimer-like, with hyperphosphorylated tau accumulating as aggregated paired helical filaments. This pathologic tau accumulates in the cell bodies and dendrites of neurons in a spatiotemporally relevant distribution.
引用
收藏
页码:582 / 590
页数:9
相关论文
共 45 条
[21]   cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease [J].
Jicha, GA ;
Weaver, C ;
Lane, E ;
Vianna, C ;
Kress, Y ;
Rockwood, J ;
Davies, P .
JOURNAL OF NEUROSCIENCE, 1999, 19 (17) :7486-7494
[22]  
Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO
[23]  
2-E
[24]  
Jicha GA, 1997, J NEUROCHEM, V69, P2087
[25]  
Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO
[26]  
2-G
[27]   DEVELOPMENTALLY REGULATED EXPRESSION OF SPECIFIC TAU SEQUENCES [J].
KOSIK, KS ;
ORECCHIO, LD ;
BAKALIS, S ;
NEVE, RL .
NEURON, 1989, 2 (04) :1389-1397
[28]   Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein [J].
Lewis, J ;
McGowan, E ;
Rockwood, J ;
Melrose, H ;
Nacharaju, P ;
Van Slegtenhorst, M ;
Gwinn-Hardy, K ;
Murphy, MP ;
Baker, M ;
Yu, X ;
Duff, K ;
Hardy, J ;
Corral, A ;
Lin, WL ;
Yen, SH ;
Dickson, DW ;
Davies, P ;
Hutton, M .
NATURE GENETICS, 2000, 25 (04) :402-405
[29]   Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP [J].
Lewis, J ;
Dickson, DW ;
Lin, WL ;
Chisholm, L ;
Corral, A ;
Jones, G ;
Yen, SH ;
Sahara, N ;
Skipper, L ;
Yager, D ;
Eckman, C ;
Hardy, J ;
Hutton, M ;
McGowan, E .
SCIENCE, 2001, 293 (5534) :1487-1491
[30]   Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation. [J].
Miyasaka, T ;
Morishima-Kawashima, M ;
Ravid, R ;
Kamphorst, W ;
Nagashima, K ;
Ihara, Y .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (09) :872-884